|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 403/12 | (2006.01) |
| C07D 401/14 | (2006.01) | ||
| C07D 231/14 | (2006.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 403/04 | (2006.01) | ||
| C07D 405/12 | (2006.01) | ||
| C07D 413/04 | (2006.01) | ||
| C07D 413/12 | (2006.01) | ||
| C07D 417/12 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61K 31/415 | (2006.01) |
| (11) | Number of the document | 3113772 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15759254.4 |
| Date of filing the European patent application | 2015-03-09 | |
| (97) | Date of publication of the European application | 2017-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (86) | Number | PCT/US2015/019535 |
| Date | 2015-03-09 |
| (87) | Number | WO 2015/134998 |
| Date | 2015-09-11 |
| (30) | Number | Date | Country code |
| 201461949808 P | 2014-03-07 | US | |
| 201461981515 P | 2014-04-18 | US |
| (72) |
KOTIAN, Pravin L., US
BABU, Yarlagadda S., US
WU, Minwan, US
CHINTAREDDY, Venkat R., US
KUMAR, V. Satish, US
ZHANG, Weihe, US
|
| (73) |
Biocryst Pharmaceuticals, Inc.,
4505 Emperor Blvd., Durham, North Carolina 27703,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Trifluormetilo pakeistieji pirazolai kaip žmogaus plazmos kalikreino inhibitoriai |
| TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 11 | 289.00 EUR |
| 2026-03-09 |